Durham, NC’s Scynexis is queuing up for a $55 million IPO, looking to ride the wave of biotech bullishness and raise cash for its in-development anti-infective.

…read more

Source: Aventis spinout Scynexis plots a $55M IPO to push an ex-Merck antibiotic